首页|期刊导航|Cancer Innovation|Extrachromosomal Circular DNA as a Cancer Biomarker:From Diagnosis to Treatment

Extrachromosomal Circular DNA as a Cancer Biomarker:From Diagnosis to Treatment

Hexin Li Jiahui Cai Gang Zhao Lihui Zou

Cancer Innovation2025，Vol.4Issue(5)：P.50-59,10.

Cancer Innovation2025，Vol.4Issue(5)：P.50-59,10.DOI:10.1002/cai2.70026

Extrachromosomal Circular DNA as a Cancer Biomarker:From Diagnosis to Treatment

Hexin Li ¹Jiahui Cai ¹Gang Zhao ²Lihui Zou³

作者信息

1. Clinical Biobank,Beijing Hospital,National Center of Gerontology,National Health Commission,Institute of Geriatric Medicine,Chinese Academy of Medical Sciences,Beijing,China
2. Department of General Surgery,Beijing Hospital,Beijing,China 3National Center of Gerontology,Institute of Geriatric Medicine,Chinese Academy of Medical Sciences,Beijing,China
3. The Key Laboratory of Geriatrics,Beijing Institute of Geriatrics,Institute of Geriatric Medicine,Chinese Academy of Medical Sciences,Beijing Hospital/National Center of Gerontology of National Health Commission,Beijing,China
折叠

摘要

关键词

biomarker/cancer/diagnosis/extrachromosomal circular DNA/treatment

分类

医药卫生

引用本文复制引用

Hexin Li,Jiahui Cai,Gang Zhao,Lihui Zou..Extrachromosomal Circular DNA as a Cancer Biomarker:From Diagnosis to Treatment[J].Cancer Innovation,2025,4(5):P.50-59,10.

基金项目

supported by the National High Level Hospital Clinical Research Fund(Grants BJ‐2024‐095,BJ‐2022‐194,and BJ‐2023‐077) （Grants BJ‐2024‐095,BJ‐2022‐194,and BJ‐2023‐077）

the CAMS Innovation Fund for Medical Sciences(2021‐I2M‐1‐050). （2021‐I2M‐1‐050）

Cancer Innovation

ISSN：2770-9191

访问量1

下载量0

段落导航